Pooled safety evaluation for a new single-shot live-attenuated chikungunya vaccine von Maurer, Gabriele, Buerger, Vera, Larcher-Senn, Julian, Erlsbacher, Florian, Dubischar, Katrin, Eder-Lingelbach, Susanne, Jaramillo, Juan Carlos

Volltext

Phase II single-arm study of a combination of obinutuzumab and venetoclax in early relapsed or refractory diffuse large B-cell lymphoma—final results of the AGMT NHL15B study von Jaeger, Ulrich, Simonitsch-Klupp, Ingrid, Klammer, Patrick, Egle, Alexander, Heibl, Sonja, Neumeister, Peter, Willenbacher, Ella, Erlsbacher, Florian, Larcher-Senn, Julian, Staber, Philipp B., Porpaczy, Edit, Skrabs, Cathrin, Mayerhoefer, Marius E., Hacker, Marcus, Melchardt, Thomas, Fridrik, Michael A., Greil, Richard

Volltext

Phase II Single-Arm “Window-of-Opportunity” Study of a Combination of Obinutuzumab and Venetoclax in Early Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) - First Resu... von Jaeger, Ulrich, Egle, Alexander, Simonitsch-Klupp, Ingrid, Heibl, Sonja, Neumeister, Peter, Willenbacher, Ella, Erlsbacher, Florian, Larcher-Senn, Julian, Fridrik, Michael A., Greil, Richard

Volltext

Combined immunogenicity evaluation for a new single-dose live-attenuated chikungunya vaccine von Buerger, Vera, Maurer, Gabriele, Kosulin, Karin, Hochreiter, Romana, Larcher-Senn, Julian, Dubischar, Katrin, Eder-Lingelbach, Susanne

Volltext